This Award Notice opportunity from Florida was posted on July 23, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Gene therapy treatments for rare genetic diseases
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Florida Department of Health has entered into contract CORKI with the University of Florida to develop gene therapy treatments for rare genetic diseases. The primary objective of this agreement is to conduct clinical Investigational New Drug enabling studies to advance these therapies toward clinical trials. The project is managed under the Public Health Statistics and Performance Management office. The original contract was valued at 750,000 dollars for the period spanning July 1, 2025, to June 30, 2026. Through Amendment A1, the contract was renewed and increased by 250,000 dollars, bringing the total funding to 1,000,000 dollars for the 2026-2027 fiscal year, effective July 1, 2026, through June 30, 2027.
General Info
Contract Value
$2,000,000NAICS
Place of Performance
FL, USASet-Aside
Awardee
UNIVERSITY OF FLORIDAAward Issued Date
Contract End Date
June 30, 2027Documents
3AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Ask CLEATUS
I've read this contract. Ask me anything.
Timeline
Organization & Contact Information
Full Description
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
